Impact of Respiratory Coinfections on Outcomes of Pneumocystis jirovecii Pneumonia in Solid Organ Transplant Recipients
Transplant Infectious Disease · 2026
DOI: 10.1111/tid.70177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2026. Verfasst von Jihyo Lim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Coinfection, Pneumonia, Pneumocystis, Organ Transplantation, Respiratory Tract Infections. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
Pneumocystis jirovecii pneumonia (PCP) is a significant opportunistic infection in solid organ transplant (SOT) recipients. However, the impact of respiratory coinfections on outcomes in this population remains unclear.
Methods
We retrospectively analyzed 112 SOT recipients diagnosed with PCP from April 2018 to March 2024. Respiratory coinfections were defined as identification of significant pathogens in respiratory specimens within 3 days of PCP diagnosis.
Results
Among 112 SOT recipients with PCP, 50.0% required intensive care unit (ICU) admission, and the 30‐day and 90‐day mortality rates were 12.5% and 17.9%, respectively. Respiratory coinfections were identified in 46 patients (41.1%), including cytomegalovirus (CMV, 30.4%), bacteria (14.3%), and non‐CMV viruses (13.4%). Bacterial coinfection was significantly associated with increased 30‐day mortality (adjusted odds ratio [aOR], 5.27; 95% confidence interval [CI], 1.15–26.27; p = 0.03) and 90‐day mortality (aOR, 4.84; 95% CI, 1.29–19.35; p = 0.02). CMV coinfection was independently associated with prolonged hospital stay (adjusted ratio, 2.42; 95% CI, 1.67–3.50; p < 0.001), higher ICU admission rates (aOR, 2.95; 95% CI, 1.04–9.03; p = 0.05), and increased need for mechanical ventilation (aOR, 3.01; 95% CI, 1.10–8.83; p = 0.04), but not with mortality. Non‐CMV viral coinfection was associated with significantly increased odds of ICU admission (aOR, 19.03; 95% CI, 2.67–254.90; p = 0.01) and mechanical ventilation (aOR, 21.21; 95% CI, 2.96–298.12; p = 0.01), without a significant impact on mortality.
Conclusion
In SOT recipients with PCP, bacterial coinfection was associated with higher mortality, while CMV and non‐CMV viral coinfections were mainly associated with morbidity. Respiratory co‐pathogens may indicate illness severity; whether pathogen‐directed strategies can modify outcomes requires further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Zitieren
APA
Lim, J., Sung, H., Lim, S. Y., Chang, E., Bae, S., Jung, J., Kim, M. J., Chong, Y. P., Kim, S. H., Choi, S. H., Kim, Y. S., & Lee, S. O. (2026). Impact of Respiratory Coinfections on Outcomes of Pneumocystis jirovecii Pneumonia in Solid Organ Transplant Recipients. Transplant Infectious Disease. https://doi.org/10.1111/tid.70177
Vancouver
Lim J, Sung H, Lim SY, Chang E, Bae S, Jung J, et al. Impact of Respiratory Coinfections on Outcomes of Pneumocystis jirovecii Pneumonia in Solid Organ Transplant Recipients. Transplant Infectious Disease. 2026. doi:10.1111/tid.70177
BibTeX
@article{Lim2026,
author = {Lim, Jihyo and Sung, Heungsup and Lim, So Yun and Chang, Euijin and Bae, Seongman and Jung, Jiwon and Kim, Min Jae and Chong, Yong Pil and Kim, Sung-Han and Choi, Sang-Ho and Kim, Yang Soo and Lee, Sang-Oh},
title = {Impact of Respiratory Coinfections on Outcomes of Pneumocystis jirovecii Pneumonia in Solid Organ Transplant Recipients},
journal = {Transplant Infectious Disease},
year = {2026},
doi = {10.1111/tid.70177}
}
EUVIMED